|Study Description:||The goal of this clinical research study is to learn if the combination of |
ipilimumab and ABI-007 (abraxane) can help to control metastatic melanoma. The
safety of this drug combination will also be studied.
Ipilimumab is designed to increase the immune system's ability to fight cancer.
ABI-007 is designed to stop cancer cells from making new DNA (the genetic
material of cells). This may stop the cancer cells from dividing into new